Carbatol CR-400 Tablet

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktīvā sastāvdaļa:

CARBAMAZEPINE

Pieejams no:

LABORATORIES TORRENT (MALAYSIA) SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

CARBAMAZEPINE

Vienības iepakojumā:

100Tablet Tablets; 30 Tablet Tablets; 10 Tablet Tablets

Ražojis:

TORRENT PHARMACEUTICALS LTD

Lietošanas instrukcija

CARBATOL-CR TABLET
_ _
Carbamazepine (200mg, 400mg)
_ _
_ _
1
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What is Carbatol-CR used for
2.
How Carbatol-CR works
3.
Before you use Carbatol-CR
4.
How to use Carbatol-CR
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Carbatol-
CR
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT CARBATOL-CR IS USED FOR
•
Carbatol-CR
is
indicated
in
the
treatment
of
various
epileptic
seizures.
•
To
control
mania
(mental
disturbance) and mood disorder.
•
To control sudden, repeated attacks
of facial pain, known as trigeminal
neuralgia.
•
Used
in
alcohol
withdrawal
syndrome.
HOW CARBATOL-CR WORKS
Carbamazepine belongs to a group of
medicines called anticonvulsants.
These medicines are thought to work by
regulating
the
way
messages
in
the
brain are passed on by nerves so that
seizures do not happen. Carbamazepine
also regulates other nerve functions in
the body.
BEFORE YOU USE CARBATOL-CR
-
_When you must not use it _
Do not take Carbatol-CR if:
•
You are allergic (hypersensitive) to
carbamazepine or any of the other
ingredients in this medicine.
•
This medicine should not be used if
you have atrioventricular block (a
type of heart block), a history of
bone marrow depression or acute
intermittent porphyria (a rare group
of blood disorders).
_Pregnancy and lactation _
_ _
_ _
Do
not
take
Carbatol-CR
if
you
are
pregnant, trying to get pregnant or think
you may be pregnant.
Do
not
take
Carbatol-CR
if
you
are
breast-feeding.
Ask
your
doctor
or
pharmacist for advice before taking any
medicine.
-
_Before you start use it _
Tell your doctor if you have, or have
had, any medical conditions, especially
the following:
•
Heart problems.
•
Liver or kidney problems.
•
Problems with your blood in the
past that were caused by medicines
you were taking.
•
A
mental
disorder
such
as
depression.
•
Have had thoughts of harming or
killing yourself.
•
Increased fluid pressure in the ey

Produkta apraksts

PRODUCT NAME
:
ITEM / PACK
:
DESIGN STYLE
:
CODE
:
DIMENSIONS (MM)
:
ART WORK SIZE
:
DATE
:
Reviewed By
NO. OF COLORS: 1
COUNTRY : Malaysia
Front/Back
Carbatol CR
Insert
S/S
180 x 350
xxxxxxxxx-5253
Black
25-05-2021
PANTONE SHADE NOS.:
ACTIVITIES
DEPARTMENT
NAME
SIGNATURE
DATE
Prepared By
PKG.DEV
PKG.DEV
LOCATION :
Chhatral
QUALITY
Approved By
complete urinalysis and BUN determinations at baseline and
periodically
thereafter are recommended.
Due to its mild anticholinergic activity, carbamazepine should be used
with
caution in patients with increased intraocular pressure and patients
should
be warned regarding the possible hazards.
Carbamazepine may also cause activation of latent psychosis and, in
elderly patients, of confusion or agitation.
Carbamazepines have been associated with decreased platelet or white
blood cell counts occuring occasionally to frequently and rarely with
agranulocytosis. The patients and their relatives should be informed
about
the early signs and symptoms indicative of potential hematological
problem
and symptoms of dermatological or hepatic reactions. The physician
should
be consulted immediately on occurrence of events like fever, sore
throat,
rash, mouth ulcers, easy bruising, petechial or purpuric hemorrhage.
The patient showing a definite low or decreased platelet count during
treatment should be closely monitored and treatment with carbamazepine
should
be
discontinued
if
any
evidence
of
significant
bone
marrow
depression appears and in case of leucopenia which is severe,
progressive
or accompanied by fever or sore throat.
Carbamazepine should be used with caution in patients with history of
liver
disease and in elderly patients and liver function tests should be
performed
before starting the carbamazepine therapy. Therapy should be
discontinued
immediately in case of acute liver disease or aggravated liver
dysfunction.
However, it should not be withdrawn in cases of abnormal liver
function
tests
resulting
from
the
hepatic
enzyme
inhibition
property
of
carbamazepine.
Mild skin react